CTMA, a clinical research service company that is working to change the way patients are detected for clinical trials, announced that Arnaud Marcel has been appointed Chief Technology Officer.
Arnaud joins CTMA with an extensive background in medical device integration; clinical surveillance and patient monitoring solutions; and software developments. Prior to joining CTMA, Arnaud spent a decade working at Capsule Technologies in positions of increasing responsibilities. Most recently, he served as Head of Software Engineering for Capsule, where he was responsible for the delivery and quality of all software developments.
Pierre Pellier, CEO of CTMA, said: “We are pleased to welcome Arnaud to CTMA at a particularly important time for the company. His vast experience and deep technical knowledge will help to advance CTMA – its investigators’ app, CT-SCOUT, and its future patients’ app, Totem4Me – with the goal of addressing the patient detection problem for clinical trials. Arnaud is a great addition to a dedicated leadership team.”
Mr. Marcel said: “I am excited to join CTMA to accelerate the company’s technology platform. CTMA is changing the way clinical trials detect patients and I look forward to playing a key role in the company’s technological developments, as it moves into its next stage.”